Options
Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia
ISSN
0268-3369
Date Issued
2019
Author(s)
Michallet, Mauricette
Dreger, Peter
Sobh, Mohamad
Koster, Linda
Hoek, Jennifer
Boumendil, Ariane
Scheid, Christof
Fox, Christopher P.
Krüger, William
van Gelder, Michel
Corradini, Paolo
Russo, Domenico
Passweg, Jakob
Schoemans, Hélène
Bethge, Wolfgang
Schaap, Nicolaas
Cornelissen, Jan
Browne, Paul
Durakovic, Nadira
Muller, Lutz
Montoto, Silvia
Kroger, Nicolaus
DOI
10.1038/s41409-019-0742-7